Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Roy Cloots"'
Autor:
Jasper Wouters, Miguel Vizoso, Anna Martinez-Cardus, F. Javier Carmona, Olivier Govaere, Teresa Laguna, Jesuchristopher Joseph, Peter Dynoodt, Claudia Aura, Mona Foth, Roy Cloots, Karin van den Hurk, Balazs Balint, Ian G. Murphy, Enda W. McDermott, Kieran Sheahan, Karin Jirström, Bjorn Nodin, Girish Mallya-Udupi, Joost J. van den Oord, William M. Gallagher, Manel Esteller
Publikováno v:
BMC Medicine, Vol 15, Iss 1, Pp 1-16 (2017)
Abstract Background Cutaneous melanoma is the deadliest skin cancer, with an increasing incidence and mortality rate. Currently, staging of patients with primary melanoma is performed using histological biomarkers such as tumor thickness and ulcerati
Externí odkaz:
https://doaj.org/article/c8d582e4e15a4836ac917268c4fb77a8
Autor:
Olivier Govaere, Teresa Laguna, Mona Foth, F. Javier Carmona, Karin Jirström, Balázs Bálint, Kieran Sheahan, Manel Esteller, William M. Gallagher, Joost van den Oord, Girish Mallya-Udupi, Anna Martínez-Cardús, Roy Cloots, Claudia Aura, Jasper Wouters, Jesuchristopher Joseph, Ian G. Murphy, Peter Dynoodt, Karin van den Hurk, Björn Nodin, Miguel Vizoso, Enda W. McDermott
Publikováno v:
BMC Medicine, Vol 15, Iss 1, Pp 1-16 (2017)
BMC Medicine, 15:101. BioMed Central Ltd
BMC Medicine
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
BMC Medicine, 15:101. BioMed Central Ltd
BMC Medicine
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname
Background Cutaneous melanoma is the deadliest skin cancer, with an increasing incidence and mortality rate. Currently, staging of patients with primary melanoma is performed using histological biomarkers such as tumor thickness and ulceration. As di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5870f2cac57623879029b50371f98559
http://link.springer.com/article/10.1186/s12916-017-0851-3
http://link.springer.com/article/10.1186/s12916-017-0851-3